Inhibitory effect of interferon-γ on experimental tooth movement in mice

Journal of Interferon and Cytokine Research

Volumn 32, Issue 9, 2012, Pages 426-431

  Kohara, Haruka ^a   Kitaura, Hideki ^b   Yoshimatsu, Masako ^a   Fujimura, Yuji ^a   Morita, Yukiko ^a   Eguchi, Toshiko ^a   Yoshida, Noriaki ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; GAMMA INTERFERON; MESSENGER RNA; STEEL;

ALVEOLAR BONE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG EFFECT; MOLAR TOOTH; MOUSE; NONHUMAN; ORTHODONTICS; OSTEOCLAST; OSTEOCLASTOGENESIS; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ACID PHOSPHATASE; ANIMALS; ANTIVIRAL AGENTS; INTERFERON-GAMMA; ISOENZYMES; MICE; MOLAR; TIME FACTORS; TOOTH MOVEMENT;

MURINAE; MUS;

EID: 84866279620     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0124     Document Type: Article

References (39)

1. Alhashimi N, Frithiof L, Brudvik P, Bakhiet M. 2000. Orthodontic movement induces high numbers of cells expressing IFN-gamma at mRNA and protein levels. J Interferon Cytokine Res 20(1):7-12. (Pubitemid 30067484)
2. Andrade I, Silva T, Silva G, Teixeira A, Teixeira M. 2007. The role of tumor necrosis factor receptor type 1 in orthodontic tooth movement. J Dent Res 86(11):1089-1094.
3. Basxaran G, Ozer T, Kaya FA, Kaplan A, Hamamci O. 2006. Interleukine-1beta and tumor necrosis factor-alpha levels in the human gingival sulcus during orthodontic treatment. Angle Orthod 76(5):830-836. (Pubitemid 44372045)
4. Billiau A, Heremans H, Vermeire K, Matthys P. 1998. Immunomodulatory properties of interferon-gamma. Ann. N Y Acad Sc 856:22-32.
5. Davidovitch Z, Nicolay OF, Ngan PW, Shanfeld JL. 1988. Neurotransmitters, cytokines, and the control of alveolar bone remodeling in orthodontics. Dent Clin North Am 32(3):411-435.
6. Dunn GP, Koebel CM, Schreiber RD. 2006. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6:836-848. (Pubitemid 44631652)
7. Fox SW, Fuller K, Bayley KE, Lean JM, Chambers TJ. 2000. TGFbeta 1 and IFN-gamma direct macrophage activation by TNFalpha to osteoclastic or cytocidal phenotype. J Immunol 165(9):4957-4963.
8. Gao Y, Grassi F, Ryan MR, Terauchi M, Page K, Yang X, Weitzmann MN, Pacifici R. 2007. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest 117(1):122-132. (Pubitemid 46048459)
9. Gao Y, Morita I, Maruo N, Kubota T, Muroa S, Aso T. 1998. Expression of IL-6 receptor and GP130 in mouse bone marrow cells during osteoclast differentiation. Bone 22(5):487-493. (Pubitemid 28226862)
10. Henneman S, Von Den Hoff JW, Maltha JC. 2008. Mechanobiology of tooth movement. Eur J Orthod 30(3):299-306.
11. Horwood NJ, Elliott J, Martin TJ, Gillespie MT. 2001. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 166(8):4915-4921. (Pubitemid 32280701)
12. Kadowaki N, Antonenko S, Lau JY, Liu YJ. 2000. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 192(2):219-226.
13. Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F, Kim JH, Kobayashi T, Odgren PR, Nakano H, YehWC, Lee SK, Lorenzo JA, Choi Y. 2005. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 202(5):589-595. (Pubitemid 41248411)
14. Kitaura H, Nagata N, Fujimura Y, Hotokezaka H, Tatamiya M, Nakao N, Yoshida N, Nakayama K. 2003. Interleukin-4 directly inhibits tumor necrosis factor-alpha-mediated osteoclast formation in mouse bone marrow macrophages. Immunol Lett 88(3):193-198. (Pubitemid 37006334)
15. Kitaura H, Nagata N, Fujimura Y, Hotokezaka H, Yoshida N, Nakayama K. 2002. Effect of IL-12 on TNF-alpha-mediated osteoclast formation in bone marrow cells: apoptosis mediated by Fas/Fas ligand interaction. J Immunol 169(9):4732-4738. (Pubitemid 35217134)
16. Kitaura H, Sands MS, Aya K, Zhou P, Hirayama T, Uthgenannt B, Wei S, Takeshita S, Novack DV, Silva MJ, Abu-Amer Y, Ross FP, Teitelbaum SL. 2004. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J Immunol 173(8):4838-4846. (Pubitemid 39387764)
17. Kitaura H, Tatamiya M, Nagata N, Fujimura Y, Eguchi T, Yoshida N, Nakayama K. 2006. IL-18 induces apoptosis of adherent bone marrow cells in TNF-alpha mediated osteoclast formation in synergy with IL-12. Immunol Lett 107(1):22-31. (Pubitemid 44332544)
18. Kitaura H, Yoshimatsu M, Fujimura Y, Eguchi T, Kohara H, Yamaguchi A, Yoshida N. 2008. An anti-c-Fms antibody inhibits orthodontic tooth movement. J Dent Res 87(4):396-400.
19. Kitaura H, Zhou P, Kim H, Novack DV, Ross FP, Teitelbaum SL. 2005. M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Invest 115(12):3818-3827.
20. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T. 2000. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKLRANK interaction. J Exp Med 191(2):275-286.
21. Kohara H, Kitaura H, Yoshimatsu M, Fujimura Y, Morita Y Eguchi T, Masuyama R, Yoshida N. 2011. IFN-g directly inhibits TNF-a-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions. Immunol Lett 137(1-2):53-61.
22. Kotake S, Nanke Y, Mogi M, Kawamoto M, Furuya T, Yago T, Kobashigawa T, Togari A, Kamatani N. 2005. IFN-gammaproducing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL. Eur J Immunol 35(11):3353-3363. (Pubitemid 41672539)
23. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103(9):1345-1352. (Pubitemid 29218305)
24. Krishnan V, Davidovitch Z. 2009. On a path to unfolding the biological mechanisms of orthodontic tooth movement. J Dent Res 88(7):597-608.
25. Lowney JJ, Norton LA, Shafer DM, Rossomando EF. 1995. Orthodontic forces increase tumor necrosis factor-a in the human gingival sulcus. Am J Orthod Dentofacial Orthop 108(5):519-524.
26. Mermut S, Bengi AO, Akin E, Kurkcu M, Karacay S. 2007. Effects of interferon-gamma on bone remodeling during experimental tooth movement. Angle Orthod 77(1):135-141.
27. Morita Y, Kitaura H, Yoshimatsu M, Fujimura Y, Kohara H, Eguchi T, Yoshida N. 2010. IL-18 inhibits TNF-alpha-induced osteoclastogenesis possibly via a T cell-independent mechanism in synergy with IL-12 in vivo. Calcif Tissue Int 86(3):242-248.
28. Nagata N, Kitaura H, Yoshida N, Nakayama K. 2003. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-g possibly induced from non-T cell population. Bone 33(4):721-732. (Pubitemid 37222399)
29. Onoe Y, Miyaura C, Kaminakayashiki T, Nagai Y, Noguchi K, Chen QR, Seo H, Ohta H, Nozawa S, Kudo I, Suda T. 1996. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J Immunol 156(2):758-764.
30. Owens JM, Gallagher AC, Chambers TJ. 1996. IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. J Immunol 157(2):936-940. (Pubitemid 26231402)
31. Storey E. 1973. The nature of tooth movement. Am J Orthod 63(3):292-314.
32. Suda T, Takahashi N, Martin TJ. 1992. Modulation of osteoclast differentiation. Endocr Rev 13(1):66-80.
33. Takayanagi H, Ogasawara K, Hida S. 2000. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408(6812):600-605.
34. Teitelbaum SL. 2000. Bone resorption by osteoclasts. Science 289(5484):1504-1508.
35. Udagawa N, Horwood NJ, Elliott J, Mackay A, Owens J, Okamura H, Kurimoto M, Chambers TJ, Martin TJ, Gillespie MT. 1997. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferongamma to inhibit osteoclast formation. J Exp Med 185(6): 1005-1012. (Pubitemid 27136793)
36. Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P. 1997. Accelerated collagen-induced arthritis in IFNgamma receptor-deficient mice. J Immunol 158(11):5507-5513. (Pubitemid 127681260)
37. Wong M, Ziring D, Korin Y, Desai S, Kim S, Lin J, Gjertson D, Braun J, Reed E, Singh RR. 2008. TNF-alpha blockade in human diseases: mechanisms and future directions. Clin Immunol 126:121-136.
38. Yoshimatsu M, Kitaura H, Fujimura Y, Eguchi T, Kohara H, Morita Y, Yoshida N. 2009. IL-12 inhibits TNF-alpha induced osteoclastogenesis via a T cell-independent mechanism in vivo. Bone 45(5):1010-1016.
39. Yoshimatsu M, Shibata Y, Kitaura H, Chang X, Moriishi T, Hashimoto F, Yoshida N, Yamaguchi A. 2006. Experimental model of tooth movement by orthodontic force in mice and its application to tumor necrosis factor receptor-deficient mice. J Bone Miner Metab 24(1):20-27. (Pubitemid 41821499)